Introduction
Colorado’s Marijuana Enforcement Division (MED) announced in April 2026 that it is pledging a significant crackdown on a practice that has been quietly undermining the state’s regulated cannabis market: manufacturers using cheap, unregulated hemp to produce products sold as licensed marijuana in state dispensaries.
The enforcement announcement, which was also reported by ProPublica, reveals a problem that goes beyond Colorado — it exposes a systemic supply chain integrity issue in the hemp-to-cannabis interface that regulators are just beginning to address at scale. For B2B hemp ingredient suppliers, the enforcement sweep is both a warning and a market signal.
What Colorado’s MED Found
Colorado’s Marijuana Enforcement Division identified what it describes as “regulatory compliance issues” involving manufacturers converting hemp into THC and marketing the resulting products through licensed dispensaries as regulated marijuana. The practice exploits price differentials between hemp-derived CBD (significantly cheaper) and licensed cannabis, allowing manufacturers to undercut the cost of compliance while benefiting from the distribution infrastructure of the licensed market.
In a high-profile 2024 case that brought the issue to public attention, state investigators found that one popular brand of marijuana vapes sold in Colorado dispensaries was actually derived from hemp and contaminated with methylene chloride — a chemical commonly used in the CBD-to-THC conversion process. The contamination represented both a compliance failure and a direct public health risk.
The MED has announced emergency rulemaking, citing “serious risks to public safety, market integrity, and the tax revenue framework that supports Colorado’s regulated cannabis industry.” Enforcement actions against companies caught using hemp or other illicit material in dispensary products now include product embargoes, license suspension or revocation, monetary penalties, and law enforcement referrals.
The Hemp-to-THC Conversion Problem Explained
The conversion of hemp-derived CBD to delta-9 THC using isomerization chemistry is not new — it has been a known practice in the hemp space since the early days of delta-8 THC commercialization. What’s changed is the scale at which it’s being used to infiltrate licensed cannabis supply chains.
The economic incentive is straightforward: hemp-derived CBD isolate is cheap and widely available. Converting it to THC and selling the product through licensed dispensaries at licensed cannabis prices generates significant margin — while bypassing the cost and regulatory complexity of growing licensed cannabis. The problem is that the converted product doesn’t have the quality controls, testing documentation, or provenance required of licensed cannabis.
Colorado’s enforcement action is specifically targeting this practice because it undermines the licensed market’s price competitiveness, creates public safety risks (the methylene chloride contamination case being the most visible example), and erodes consumer trust in the licensed cannabis framework.
What This Means for Legitimate B2B Hemp Ingredient Suppliers
Colorado’s crackdown has implications that extend well beyond the state’s cannabis market:
Supply chain documentation is becoming a differentiator. In a market where hemp ingredients are being used to adulterate licensed cannabis products, buyers at every level of the supply chain will increasingly demand documentation of ingredient provenance. COAs that trace back to verified hemp cultivation, compliant processing, and ISO 17025 testing are worth more because they are verifiable.
The hemp industry’s reputational stakes are rising. The Colorado story — involving a popular dispensary brand contaminated with a chemical solvent — is exactly the kind of news that accelerates both regulatory crackdowns and consumer skepticism. Legitimate B2B hemp suppliers have every incentive to distance themselves from conversion chemistry practices and to make their documentation standards conspicuous.
Enforcement creates market opportunity. As Colorado and other states move to enforce supply chain integrity, the manufacturers who have been using hemp-based shortcuts will be pushed out of the market. The suppliers who can fill that void with verified, documented ingredients will benefit from the enforcement-driven consolidation.
The federal November 12 deadline adds pressure. With federal enforcement of the total THC standard approaching, the regulatory environment for hemp ingredient sourcing is getting stricter on multiple dimensions simultaneously. Companies that can document clean supply chains — no conversion chemistry, no adulteration, verified cannabinoid profiles — will be the ones that survive and grow.
The Broader Signal for State Cannabis Markets
Colorado is not alone in grappling with hemp infiltration of licensed cannabis supply chains. As hemp-derived cannabinoids have become cheaper and more widely available, the incentive to use them as substitutes for cultivated cannabis inputs has grown across multiple state markets.
Expect other states with licensed cannabis markets — California, Washington, Oregon, Michigan — to implement similar enforcement mechanisms over the coming months. The Colorado case has provided a public, ProPublica-reported template that state regulators in other markets can point to as justification for their own supply chain integrity enforcement.
For hemp operators who have built their business on transparent, verified ingredient supply, this enforcement wave is net positive. The gray market competition you’ve been facing is about to face significant regulatory headwinds.
🌿 LGH Perspective
Low Gravity Hemp supplies hemp ingredients — not conversion chemistry. Our broad-spectrum distillate, CBD isolate, and hemp extract products are sourced from compliant hemp cultivation and processed without the isomerization chemistry that has created the Colorado problem. Our COAs document what’s in our products and how they were made. In an environment where supply chain integrity is becoming a market filter, that documentation is a business asset for our customers.
Final Thoughts
Colorado’s enforcement action is a market correction event. The practice of using cheap hemp to undercut the licensed cannabis market was always going to attract enforcement attention — the ProPublica coverage and the methylene chloride contamination case simply accelerated the timeline.
For B2B hemp suppliers operating transparently and for brands sourcing from verified ingredient suppliers, the Colorado crackdown is an inflection point: the market is moving toward your business model, not away from it.
Reach out to Low Gravity Hemp to discuss verified, documented B2B hemp ingredient sourcing with full supply chain transparency.
